Hericium erinaceus supplementation improves symptoms of sleep disorders
A systematic review of five RCTs and three pilot clinical trials found that Hericium erinaceus (Lion's Mane mushroom) reduced symptoms of sleep disorders. The review also reported cognitive improvements, with a combined weighted mean increase of 1.17 on the Mini-Mental State Examination in intervention groups.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Hericium erinaceus supplementation improves symptoms of sleep disorders The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 34/100 (low).
The Claim
Hericium erinaceus supplementation improves symptoms of sleep disorders
This conclusion is most relevant to: Participants with and without dementia, including those with mood dysregulation.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review. (Frontiers in nutrition, 2025) —
How It Works
The proposed biological pathway:
- ▸HE enhances pro-BDNF and BDNF production
- ▸Promotes hippocampal neurogenesis
- ▸Improves behavior and mood regulation
- ▸Reduces symptoms of sleep disorders
Who Might Benefit
Evidence fit by population:
- ▸Participants with and without dementia, including those with mood dysregulation
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Only one systematic review with limited number of RCTs (5) and pilot trials (3) specifically addressing sleep outcomes
- ▸Potential side effects (stomach discomfort, headache, allergic reactions) were commonly unreported, limiting safety assessment
References
- 1.Menon A, Jalal A, Arshad Z, Nawaz FA, Kashyap R. “Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review..” Frontiers in nutrition, 2025. PMID: 40959699 DOI: 10.3389/fnut.2025.1641246